Objective: To assess the effectiveness of site-specific manual soft tissue therapy in (1) facilitating natural fertility and (2) improving in vitro fertilization (IVF) pregnancy rates in women ...
Talimogene laherparepvec is under clinical development by Amgen and currently in Phase II for Soft Tissue Sarcoma.
Tevimbra is under clinical development by BeiGene and currently in Phase II for Soft Tissue Sarcoma. According to GlobalData, Phase II drugs for Soft Tissue Sarcoma have a 26% phase transition success ...
The FDA has given accelerated approval to a groundbreaking T cell-based therapy from Adaptimmune for synovial sarcoma, becoming the first new treatment for the rare soft tissue cancer in more than ...
When these knots or bands of scar tissue are encountered, both the clinician and the patient sense a restriction, almost like a speed bump or a granular feeling. The instrument can then be used to ...
Kerecis, announced the availability of SurgiClose® Silicone, which combines a fish-skin graft and silicone backing for ...
"FDA awards GSK breakthrough status for relapsed osteosarcoma treatment" was originally created and published by ...
4 天
Zacks.com on MSNGSK's ADC Drug Gets FDA's Breakthrough Tag for Rare Bone CancerGSK plc GSK announced that the FDA has granted a Breakthrough Therapy Designation to its investigational B7-H3-targeted ...
The SU2C-SARC032 study demonstrated that pembrolizumab combined with radiotherapy and surgery was well tolerated, with ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果